# BrainsWay Ltd. (BWAY)

> Source: Nexqual · https://nexqual.com/BWAY · data as of 2026-10-29 20:00 UTC · cite as "Nexqual, BrainsWay Ltd. (BWAY), nexqual.com/BWAY" · informational, not investment advice.

**Price:** USD 11.93 (+4.93% on the day) · last close of Oct 29, 2026; US market closed, not a live price. Prev close 11.37 · day 11.59–12.05 · 52w 7.14–17.4 · market cap $480M · NGM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (3 analysts), mean target USD 19.27 (range 18.8–20).
- Total return with dividends: 1Y +33.8% vs S&P 500 +14.8%; 5Y +191.7% vs S&P 500 +79.1%.
- Next earnings: 2026-11-10, EPS estimate USD 0.09, revenue estimate $17.8M. All companies reporting that day: https://nexqual.com/earnings/2026-11-10
- Dividend: BWAY paid no cash dividend in the last five years.
- Short interest: 0.74% of float (as of 2026-10-15), 2.0 days to cover.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 19.27 (low 18.8, high 20).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | HC Wainwright & Co. | Reiterated | Buy | $19 |
| 2026-09-10 | BTIG | Reiterated | Buy | $20 |
| 2026-09-08 | HC Wainwright & Co. | Reiterated | Buy | $19 |
| 2026-08-31 | HC Wainwright & Co. | Target raised | Buy | $17 → $19 |
| 2026-08-13 | Ladenburg Thalmann | Target raised | Buy | $18 → $18.8 |
| 2026-08-12 | BTIG | Target raised | Buy | $18 → $20 |
| 2026-07-20 | BTIG | Initiated | Buy | $18 |
| 2026-07-02 | HC Wainwright & Co. | Reiterated | Buy | $17 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-30) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +33.8% | +191.7% |
| S&P 500 (SPY) | +14.8% | +79.1% |
| Per year | +34.1% | +23.8% |
| Volatility (annualized) | 53.1% | 64.2% |
| Max drawdown | -34.7% (May 2026→Oct 2026) | -83.4% (Apr 2022→May 2023) |

## Dividends
BWAY paid no cash dividend in the last five years.

## Short interest
226,033 shares sold short, 0.74% of the float, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 199,566 shares (+13.3%). Days to cover: 2.0 (short shares ÷ average daily volume).

## Peers (Medical Devices)
ATEC (Alphatec Holdings, Inc.) USD 11.37 -0.70% · BFLY (Butterfly Network, Inc.) USD 7.51 -3.84% · ESTA (Establishment Labs Holdings Inc) USD 68.41 -0.81% · INSP (Inspire Medical Systems, Inc.) USD 71.18 +0.30% · UFPT (UFP Technologies, Inc.) USD 293.3 +2.55% · TMDX (TransMedics Group, Inc.) USD 67.12 +0.33%

## More
Full page: https://nexqual.com/BWAY · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.09 | $0.09 | +0.0% | $17.8M | 3 |
| Next quarter (ends 2026-12-31) | $0.09 | $0.09 | +3.7% | $18.7M | 3 |
| Current fiscal year (ends 2026-12-31) | $0.31 | $0.31 | +0.0% | $69.2M | 3 |
| Next fiscal year (ends 2027-12-31) | $0.51 | $0.48 | +4.8% | $85.3M | 3 |

## Earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.07 | $0.07 | In line | — |
| — | Quarter ended Mar 31, 2026 | $0.06 | $0.05 | Beat +20.0% | — |
| — | Quarter ended Dec 31, 2025 | $0.06 | $0.03 | Beat +$0.03 | — |
| — | Quarter ended Sep 30, 2025 | $0.02 | $0.02 | In line | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).